Interesting facts
Interesting Facts about 1-Cyclopropyl-6-fluoro-4-oxo-7-piperazin-1-yl-quinoline-3-carboxylic Acid
This intriguing compound, known as 1-cyclopropyl-6-fluoro-4-oxo-7-piperazin-1-yl-quinoline-3-carboxylic acid, belongs to the quinoline family, a group of compounds recognized for their diverse biological activities. Here are some interesting aspects:
- Pharmaceutical Potential: Compounds in the quinoline class are often explored for their therapeutic properties, particularly in anti-infective and anti-cancer research.
- Mechanism of Action: The unique structure of this compound suggests potential mechanisms in inhibiting bacterial growth or acting on specific metabolic pathways, making it a candidate for further pharmacological studies.
- Structural Features: The presence of both a piperazine ring and a fluorine atom may dramatically influence the compound’s interaction with biological targets, thereby enhancing its potency or bioavailability.
- Research Focus: Many scientists are intrigued by the role of halogens, such as fluorine, in modifying the properties of organic molecules, which can lead to increased stability and solubility in biological systems.
- Synthetic Interest: The synthesis of this compound can serve as a model for developing new methods in organic chemistry, particularly in the creation of complex molecules with multiple functional groups.
As a chemistry student or researcher, one might find it captivating to delve into how such compounds can pave the way for novel drug discovery. The study of such compounds not only contributes to our understanding of chemical reactivity but also has the potential to improve public health through the development of new medicinal therapies.
In the words of Nobel laureate Richard Feynman, “The science of today is the technology of tomorrow.” With compounds like this, we stand at the crossroads of science and potential, ready to explore what new horizons might be opened.
Synonyms
ciprofloxacin
85721-33-1
Ciprofloxacine
Ciprobay
Cipro
Ciprofloxacina
Ciproxan
Ciprofloxacino
Ciprofloxacinum
Cipro IV
Ciprocinol
Cipromycin
Ciproquinol
Bacquinor
Bernoflox
Cifloxin
Ciprodar
Otiprio
Septicide
BAY q 3939
1-Cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-quinolinecarboxylic acid
Ciprogis
Ciprolin
Ciprolon
Ciprowin
Ciproxina
Ciproxine
Citopcin
Corsacin
Fimoflox
Proflaxin
Quinolid
Spitacin
Superocin
Zumaflox
Baflox
Ciplus
Ciprecu
Ciriax
Ipiflox
Italnik
Probiox
Quintor
Rancif
Roxytal
Cilab
Cixan
Cycin
Loxan
Unex
Sophixin Ofteno
Ciprobay Uro
Alcon Cilox
Bi-Cipro
1-cyclopropyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid
Cetraxal
Ciproflox
Cyprobay
Proksi 250
Proksi 500
AuriPro
Cipro XR
BAYQ3939
CPFX
1-Cyclopropyl-6-fluoro-4-oxo-7-(1-piperazinyl)-1,4-dihydro-3-quinolinecarboxylic acid
CCRIS 5241
Linhaliq
Bay-09867
HSDB 6987
1-cyclopropyl-6-fluoro-4-oxo-7-piperazin-1-ylquinoline-3-carboxylic acid
UNII-5E8K9I0O4U
Ciprofloxacine [INN-French]
Ciprofloxacinum [INN-Latin]
Ciprofloxacino [INN-Spanish]
Ciproxin
NSC-758467
BRN 3568352
5E8K9I0O4U
1-CYCLOPROPYL-6-FLUORO-4-OXO-7-PIPERAZIN-1-YL-1,4-DIHYDROQUINOLINE-3-CARBOXYLIC ACID
CIPRO IN DEXTROSE 5% IN PLASTIC CONTAINER
BAY O 9867 FREE BASE
BAY-O-9867 FREE BASE
CHEMBL8
CHEBI:100241
BAY-Q-3939
CIPRO IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
3-Quinolinecarboxylic acid, 1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-
MFCD00185755
Ciprinol
DTXSID8022824
BAY-O9867
Velmonit
Ciprofloxacin [USAN:USP:INN:BAN]
3-Quinolinecarboxylic acid, 1,4-dihydro-1-cyclopropyl-6-fluoro-4-oxo-7-(1-piperazinyl)-
CIPRODEX COMPONENT CIPROFLOXACIN
NSC 758467
Eni
1-cyclopropyl-6-fluoro-4-oxo-7-piperazin-1-yl-quinoline-3-carboxylic acid
Cipro (TN)
1-Cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-quinoline-carboxylic acid
1-Cyclopropyl-6-fluoro-4-oxo-7-piperazin-1-yl-1,4-dihydro-quinoline-3-carboxylic acid
1-cyclopropyl-6-fluoro-7-hexahydro-1-pyrazinyl-4-oxo-1,4-dihydro-3-quinolinecarboxylic acid
Ciprofloxacine (INN-French)
Ciprofloxacinum (INN-Latin)
1-Cyclopropyl-6-fluoro-7-(4-methyl-piperazin-1-yl)-4-oxo-1,4-dihydro-quinoline-3-carboxylic acid
Ciprofloxacino (INN-Spanish)
CIPROFLOXACIN (MART.)
CIPROFLOXACIN [MART.]
CIPROFLOXACIN (USP-RS)
CIPROFLOXACIN [USP-RS]
Linhaliq (Liposomal Formulation)
Linhaliq [Liposomal Formulation]
CIPROFLOXACIN (EP MONOGRAPH)
CIPROFLOXACIN [EP MONOGRAPH]
Ciprofloxacin (USAN:USP:INN:BAN)
CIPROFLOXACIN (USP MONOGRAPH)
CIPROFLOXACIN [USP MONOGRAPH]
BAY-o 9867
SMR000471901
NSC620634
SR-05000001863
NCGC00016959-01
CAS-93107-08-5
rubrum
Ciprooxacin
Ciprine
ENROFLOXACIN FOR VETERINARY USE IMPURITY B (EP IMPURITY)
ENROFLOXACIN FOR VETERINARY USE IMPURITY B [EP IMPURITY]
Ciprofloxacin In Dextrose 5%
Ciprofloxacin monohydrochloride
Bay 09867
Ciprofloxacin,(S)
Otiprio (TN)
Ciprofloxacin (Cipro)
Spectrum_000162
Ciprofloxacin (Cipro)?
Ciprofloxacin protomer I
Ciprofloxacin (Standard)
Ciprofloxacin in Dextrose
3-Quinolinecarboxylic acid, 1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-, hydrochloride
Ciprofloxacin protomer II
Prestwick0_000113
Prestwick1_000113
Prestwick2_000113
Prestwick3_000113
Spectrum2_001567
Spectrum3_001872
Spectrum4_000874
Spectrum5_001089
Cipro (*Hydrochloride*)
CBMicro_048498
CIPROFLOXACIN [MI]
Ciloxan (*Hydrochloride*)
ciprofloxacin by-compound a
CIPROFLOXACIN [INN]
CIPROFLOXACIN [JAN]
SCHEMBL2900
CIPROFLOXACIN [HSDB]
CIPROFLOXACIN [USAN]
Oprea1_008239
Oprea1_313572
BSPBio_000126
BSPBio_003344
CIPROFLOXACIN [VANDF]
KBioGR_001567
KBioSS_000642
ANHYDROUS CIPROFLOXACIN
Ciprofloxacin In Dextrose 5% In Plastic Container
MLS001336035
MLS006011837
BIDD:GT0205
DivK1c_000095
SPECTRUM1503614
BAY q3939
SPBio_001474
SPBio_002065
CIPROFLOXACIN [WHO-DD]
CIPROFLOXACIN [WHO-IP]
ciprofloxacin desfluoro-compound
BPBio1_000140
DTXCID002824
BDBM21690
GTPL10902
HMS500E17
HY-B0356R
KBio1_000095
KBio2_000642
KBio2_003210
KBio2_005778
KBio3_002846
Ciprofloxacin (JP18/USP/INN)
J01MA02
S01AE03
S02AA15
S03AA07
NINDS_000095
Bay o 9867 (*Hydrochloride*)
HMS1922E18
HMS2090O07
HMS2093I03
Pharmakon1600-01503614
CIPROFLOXACIN [ORANGE BOOK]
ALBB-015909
BCP28586
FVB05035
HY-B0356
RKL10073
BBL005612
CCG-39345
CIPROFLOXACIN EXTENDED RELEASE
Ciprofloxacin, >=98.0% (HPLC)
NSC758467
NSC759028
s2027
STK021082
719 - Quinolone antibiotics in fish
1-cyclopropyl-6-fluoro-4-oxo-7-piperazinylhydroquinoline-3-carboxylic acid
AKOS000269653
CIPROFLOXACINUM [WHO-IP LATIN]
AC-7613
AC58172
DB00537
KS-5006
NSC-759028
IDI1_000095
SMP1_000125
Ciprofloxacin 100 microg/mL in Methanol
NCGC00016959-02
NCGC00016959-03
NCGC00016959-04
NCGC00016959-05
NCGC00016959-07
NCGC00095058-01
NCGC00095058-02
NCGC00178128-01
CIPROFLOXACIN COMPONENT OF CIPRODEX
SBI-0048462.P003
C2510
NS00008031
EN300-08481
C05349
D00186
Ciprofloxacin, VETRANAL(TM), analytical standard
Q256602
SR-05000001863-1
SR-05000001863-3
BRD-K04804440-001-08-7
BRD-K04804440-001-09-5
BRD-K04804440-001-13-7
BRD-K04804440-311-02-3
Z56933707
Ciprofloxacin, European Pharmacopoeia (EP) Reference Standard
Ciprofloxacin, United States Pharmacopeia (USP) Reference Standard
1-Cyclopropyl-6-fluoro-1,4-dihydro 4-oxo-7-[1-piperazinyl)-quinoline-3-carboxylic Acid
1-Cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7- (1-piperazinyl)-3-quinoline-carboxylic acid
1-Cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3- quinolinecarboxylic acid
1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-quinoline -3-carboxylic acid
1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-quinoline-3-carboxylic acid
1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)quinoline-3-carboxylic acid
1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1piperazinyl)-3quinolinecarboxylic acid
1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(piperazin-1-yl)-quinoline-3-carboxylic acid
1-Cyclopropyl-6-fluoro-1,4-dihydro-7-(1-piperazinyl)-4-oxo-3-quinoline carboxylic acid
1-Cyclopropyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid
1-cyclopropyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylicacid
1-cyclopropyl-6-fluoro-7-(piperazin-1-yl)-1,4-dihydro-4-oxoquinoline-3-carboxylic acid
Ciprofloxacin, Pharmaceutical Secondary Standard; Certified Reference Material
1-Cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-quinolinecarboxylic acid;Ciflafin;Bay q 3939
1-cyclopropyl-6-fluoro-4-oxo-7-piperazin-1-yl-1,4-dihydroquinoline-3-carboxylic acid hydrochloride
Solubility of 1-cyclopropyl-6-fluoro-4-oxo-7-piperazin-1-yl-quinoline-3-carboxylic acid
The solubility of 1-cyclopropyl-6-fluoro-4-oxo-7-piperazin-1-yl-quinoline-3-carboxylic acid (C17H18FN3O3) is a topic of considerable interest due to its potential applications in pharmaceutical formulations. Understanding its solubility characteristics is crucial for its efficacy and bioavailability. Here is what we know:
Considering these factors, it is clear that the solubility of this compound is influenced by a range of environmental conditions. As stated in numerous studies, “*knowledge of solubility is the first step towards the effective formulation of any medicinal compound*” – highlighting its critical role in drug design and delivery.